In this study, we present findings from administering dupilumab to a cohort of 40 CRSwNP patients, focusing on its impact on key clinical parameters such as symptom scores, polyp size, and biomarkers like total IgE and peripheral eosinophilia. The gene discussed is IGHE; the disease is chronic rhinosinusitis with nasal polyps.